- Home
- NTIP vs BMGL Comparison
NTIP vs BMGL Comparison
Compare NTIP & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- BMGL
- Stock Information
- Founded
- NTIP 1990
- BMGL 2001
- Country
- NTIP United States
- BMGL Singapore
- Employees
- NTIP N/A
- BMGL N/A
- Industry
- NTIP Multi-Sector Companies
- BMGL
- Sector
- NTIP Miscellaneous
- BMGL
- Exchange
- NTIP Nasdaq
- BMGL NYSE
- Market Cap
- NTIP 28.6M
- BMGL 33.8M
- IPO Year
- NTIP 1998
- BMGL 2025
- Fundamental
- Price
- NTIP $1.25
- BMGL $1.75
- Analyst Decision
- NTIP
- BMGL
- Analyst Count
- NTIP 0
- BMGL 0
- Target Price
- NTIP N/A
- BMGL N/A
- AVG Volume (30 Days)
- NTIP 13.9K
- BMGL 1.1M
- Earning Date
- NTIP 08-11-2025
- BMGL 01-01-0001
- Dividend Yield
- NTIP 8.00%
- BMGL N/A
- EPS Growth
- NTIP N/A
- BMGL N/A
- EPS
- NTIP N/A
- BMGL 0.02
- Revenue
- NTIP $250,000.00
- BMGL $7,342,469.00
- Revenue This Year
- NTIP N/A
- BMGL N/A
- Revenue Next Year
- NTIP N/A
- BMGL N/A
- P/E Ratio
- NTIP N/A
- BMGL $88.88
- Revenue Growth
- NTIP N/A
- BMGL 2.28
- 52 Week Low
- NTIP $1.16
- BMGL $0.91
- 52 Week High
- NTIP $1.78
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- NTIP 51.66
- BMGL N/A
- Support Level
- NTIP $1.21
- BMGL N/A
- Resistance Level
- NTIP $1.30
- BMGL N/A
- Average True Range (ATR)
- NTIP 0.05
- BMGL 0.00
- MACD
- NTIP -0.00
- BMGL 0.00
- Stochastic Oscillator
- NTIP 64.29
- BMGL 0.00
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.